Navigation Links
Leukemia in Medical Technology

British Woman Celebrates a Year of Living Cancer-Free

... body's immune system, will target and fight any leukemia cells that survive chemotherapy if they are ... bone marrow -- the site affected by the type of leukemia she had -- confirmed that the TaNK cells were ... felt when she was diagnosed with acute myeloid leukemia (AML) four years ago. AML is a cancer of the ...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

... anti-tumor activity. Access is now working with leukemia and lymphoma specialists to initiate additional Phase 2 clinical trials in acute myeloid leukemia (AML) , acute lymphocytic leukemia (ALL) and other indications. "The IND for ...

Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

... avoid the use of radiation in acute lymphoblastic leukemia treatment MEMPHIS, Tenn., June 24 /PRNewswire-USNewswire/ -- Childhood acute lymphoblastic leukemia (ALL) can be successfully treated using a ... ALL treatment to prevent recurrence of the leukemia in the central nervous system (CNS). ...

Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients

... a high response rate in acute lymphoblastic leukemia (ALL) patients with minimal residual disease ... with B precursor acute lymphoblastic leukemia (ALL): Update of an ongoing Phase II ... treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 clinical trial for the ...

Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

... anti-tumor activity. Access is working with leukemia and lymphoma specialists at M.D. Anderson ... Phase 2 clinical trials in acute myeloid leukemia (AML) , acute lymphocytic leukemia (ALL) and other indications. Additionally, we ...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

... and relapsed or refractory chronic lymphocytic leukemia (CLL). TRU-016 is the Company's proprietary ... for the treatment of CLL and small lymphocytic leukemia (SLL). The objectives of the Phase 1 TRU-016 CLL ... was 67% and was as high as 98%. Two patients with leukemia cutis had complete or partial clearance of skin ...

FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)

... benefit for patients with chronic lymphocytic leukemia (CLL) whose disease is refractory to fludarabine ... CLL is the most common form of adult leukemia in the Western world, and the treatment of ... About CLL CLL is the most common adult leukemia and one of the most common malignant lymphoid ...

Mutant Genes in High-Risk Childhood Leukemias Identified

... identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. ... specific drugs that could treat this high-risk leukemia subtype in children, particularly because such ... underlie such cases. "Our studies of these leukemia subtypes indicate ...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

... to help children with acute myeloid leukemia (AML). Dr. Ge is an Assistant Professor at the ... in bone marrow, accounts for one-fourth of acute leukemia in children and is responsible for more than half of the leukemia deaths in this population. Approximately 600 ...

Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis

... Medicine employs Quest Diagnostics' blood-based leukemia testing MADISON, N.J., Feb. 20 ... years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published ... affected. Although CLL is the most common form of leukemia in adults in Western countries, little is known ...

EntreMed Presents Initial Clinical Results for ENMD-2076

... Phase 1 studies underway, a Phase 1 study for leukemia is being planned; and now orphan drug designation ... study and the expected commencement of the leukemia study, the program covers a spectrum of potential ... start of the Phase 1 multiple myeloma and leukemia studies will allow us to start treatment at a ...

St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment

... in the body for children with acute lymphoblastic leukemia MEMPHIS, Tenn., Jan. 27 ... discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that ... of studying genetic variations acquired by leukemia cells, scientists identified small genetic ...

The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML

... and PRINCETON, N.J., Jan. 22 /PRNewswire/ -- The leukemia & Lymphoma Society (LLS) and Celator ... for treatment of adults with acute myeloid leukemia (AML). Through the partnership, LLS will ... of AML." "We are very pleased that The leukemia & Lymphoma Society sees the potential of ...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

... of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that ... in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the findings are likely to provide the ... the study, researchers analyzed genetic data on leukemia cells obtained at diagnosis from 221 children ...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

... showed activity in high-risk chronic lymphocytic leukemia (CLL) patients who have poor prognostic ... States are living with CLL, according to the leukemia and Lymphoma Society. More people are living with ... Clinical Outcome of B-Cell Chronic Lymphocytic leukemia Following Alemtuzumab Therapy: Retrospective ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... newly diagnosed patients with chronic myeloid leukemia Two separate studies show rapid ... Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in early chronic phase achieved a ... MD, Professor of Medicine and Deputy Chair of leukemia at the University of Texas MD Anderson Cancer ...

New Study Shows PCR and FCR Have Significant Activity in B-cell Chronic Lymphocytic Leukemia

... PCR in patients with B-cell chronic lymphocytic leukemia (CLL). The study results will be given ... ASH conference: Acute M y eloid leukemia (AML) Roger Lyons, M.D., ... older adult patients with acute myelogeneous leukemia (AML) unlikely to benefit from standard induction ...

Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)

... (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia. The ... patients with AML. About Acute Myeloid leukemia (AML) Acute myeloid leukemia is a rapidly progressing cancer of the blood and ...

Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)

... the treatment of refractory chronic lymphocytic leukemia (CLL). The results demonstrate the potential of ... 2009. CLL is the most common form of leukemia in the Western world,(2) and the treatment of ... About CLL CLL is the most common leukemia and one of the most common malignant lymphoid ...

Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology

... diagnosed and relapsed/refractory acute myeloid leukemia (AML). These data were presented today at two ... said Judith E. Karp, M.D., Director, Adult leukemia Program at The Sidney Kimmel Comprehensive Cancer ... December 23, 2008. About Acute Myeloid leukemia AML is a rapidly progressing cancer of the ...

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

... stem cell transplantation for patients with acute leukemia is an unrelated adult donor whose tissue type ... of the outcomes of 1,240 adults with acute leukemia (707 patients with acute myeloid leukemia and 533 patients with acute lymphocytic leukemia) ...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

... the ASH press conference on treatment advances in leukemia and lymphoma to respond to questions on this ... the ASH press conference on treatment advances in leukemia and lymphoma. The embargo for this abstract will ... with relapsed or refractory chronic lymphocytic leukemia were randomized to receive six 28-day cycles of ...

Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome

... types of rapid-growing cancers, particularly leukemia or lymphoma. The syndrome develops when a ... of Medicine and Deputy Chair, Department of leukemia at The University of Texas , MD Anderson Cancer ... Lymphoma (REAL) criteria, acute myeloid leukemia (AML), chronic ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

... as prognostic indicators for chronic lymphocytic leukemia (CLL) and side effects such as ... for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). Leukine is indicated for use following ... 55 years and older with acute myelogenous leukemia (AML) to shorten the time to neutrophil recovery ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH ... Diagnosed, Previously Untreated Chronic Myeloid leukemia in Chronic Phase (CML-CP) Using Molecular ... chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in the chronic phase. Follow-up is limited ...

The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial

... WHITE PLAINS, N.Y., Dec. 3 /PRNewswire/ -- The leukemia & Lymphoma Society (LLS) and Memgen, LLC ... refractory and/or 17p deleted chronic lymphocytic leukemia (CLL). Doctors at UCSD have already ... visit www.memgenbio.com . About The leukemia & Lymphoma Society ...

Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH

... from its studies of voreloxin in acute myeloid leukemia (AML) will be presented during the 50th American ... kinases 2, 7 and 9, in both chronic lymphocytic leukemia and multiple myeloma will be presented. ... Patients with Newly Diagnosed Acute Myeloid leukemia (AML): Preliminary Safety and Clinical Responses ...

St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse

... study finds the majority of acute lymphoblastic leukemia relapse cases arise from a cell already present ... cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse. The finding offers a ... distinct cells, indicating that the relapsed leukemia was actually an entirely new cancer. ...

Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351

... in patients with newly diagnosed acute myeloid leukemia (AML). The first patient was enrolled by ... Ratios Delivered by CPX-351 to Human leukemia Xenografts is Associated with Liposome-Mediated ... Intracellular Delivery of Encapsulated Agents to leukemia Cells, and Increased Efficacy will be presented ...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

... Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. Follow-up ... relapsed or refractory Ph+ acute lymphoblastic leukemia (Ph+ ALL); adult patients with ... syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFRa fusion kinase ...

Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients

... options." Dr. Norbert Vey, Head of the leukemia Service of the Institut Paoli-Calmettes and Chief ... is a very serious form of leukemia from which few patients can be cured currently. ... untreated de novo poor-risk acute myelogenous leukemia (AML). The Company is also conducting clinical ...

Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody

... for patients with B-cell chronic lymphocytic leukemia and other hematologic and solid-tumor cancers." ... or relapsing B-cell Chronic Lymphocytic leukemia ("CLL"). As previously announced, dosing in ... About CLL CLL is the second most common type of leukemia in adults. (2) The American Cancer Society ...

Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156

... made possible, in part, by funding from The leukemia & Lymphoma Society, is entitled "A Phase 1-2, ... with relapsed or refractory chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and ... indications. I must also thank, once again, The leukemia & Lymphoma Society for their financial support of ...

University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society

... WHITE PLAINS, N.Y., July 7 /PRNewswire/ -- The leukemia & Lymphoma Society has awarded a $550,000 grant ... in established and new laboratories. About The leukemia & Lymphoma Society The leukemia & Lymphoma Society(R), headquartered in White ...

The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial

... WHITE PLAINS, N.Y., June 18 /PRNewswire/ -- The leukemia & Lymphoma Society (LLS) and Memgen jointly ... is very pleased to be working with The leukemia & Lymphoma Society. ISF35 has the potential to ... visit http://www.memgenbio.com . About The leukemia & Lymphoma Society ...

Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress

... of voreloxin in relapsed or refractory acute leukemia patients will be presented at the 13th Congress ... cytarabine in relapsed/refractory acute myeloid leukemia (AML) patients. In addition, data from the ... of SNS-032 in patients with chronic lymphocytic leukemia and multiple myeloma will be presented at EHA. ...

Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting

... chromosome-positive chronic myeloid leukemia to be presented EAST HANOVER, N.J., May 15 ... with imatinib-resistant chronic myeloid leukemia in chronic phase (Abstract #7010: Monday, June ... chromosome-positive chronic myeloid leukemia (Ph+ CML). ASA404 is an investigational ...

The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement

... WHITE PLAINS, N.Y., April 16 /PRNewswire/ -- The leukemia & Lymphoma Society (LLS) and Anjin Group, Inc. ... see http://www.anjingroup.com . About The leukemia & Lymphoma Society The leukemia & Lymphoma Society(R), headquartered in White ...

Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

... and in vivo activity as well as tolerability in leukemia xenograft models, and further elucidating the NEI ... Export Inhibitors (NEIs) in Multiple Murine leukemia Models" presented data from NEI compounds tested ... models of leukemia, including acute lymphoblastic leukemia (ALL) and acute ...

St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia

... in childhood acute lymphoblastic leukemia (ALL) could offer a pathway to predicting such ... have successfully used laboratory studies of leukemia cells to explore the basis of resistance in other ... genes was not surprising because the drug kills leukemia cells by interfering with their ability ...
Other Contents
(Date:7/11/2014)... The Chinese University of Hong Kong, BGI and other ... to salt tolerance, with implication for improving this important ... online in Nature Communications provides an effective ... , Soybean is an important crop for the world. ... less genetic diversities than their wild counterparts. Among the ...
(Date:7/11/2014)... group members to reduce aggression and gain access to ... grooming activities shows a certain pattern across the day. ... Biology Letters . , Grooming between individuals in ... motives. To be groomed has hygienic benefits and is ... can provide access to infants, mating opportunities and high ...
(Date:7/11/2014)... two different ways that allow unprecedented experimental insights ... of oxygen molecules in photosynthesis. The two studies ... Nature Communications . , "The new knowledge will ... oxidation, which are key components for building artificial ... energy in fuels like hydrogen, ethanol or methanol," ...
Breaking Biology News(10 mins):BGI reports a novel gene for salt tolerance found in wild soybean 2Baboons groom early in the day to get benefits later 2Molecular snapshots of oxygen formation in photosynthesis 2
(Date:7/13/2014)... 2014 The North American water storage systems ... to $5,450 million by 2018, at a CAGR of 21.0%, ... expanding at a rapid pace in North America. The U.S. ... on water & wastewater storage and collection, and the increased ... is expanding at a healthy rate in Canada, and is ...
(Date:7/13/2014)... July 13, 2014 The report ... Molybdenum, Iron), Form (Chelated & Non Chelated), Application ... - Global Trends and Forecast to 2018” defines ... an analysis and forecasting of the global value ... the driving and restraining factors for the global ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
(Date:7/13/2014)... 13, 2014 MarketsandMarkets recently conducted ... Modeling; 3D Scanning; 3D rendering; Layout and Animation; ... (2013 - 2018)”, which analyzes and studies the ... America, Western Europe, Eastern Europe, Middle East and ... draws the competitive landscape of the 3D imaging ...
(Date:7/13/2014)... Serena Gordon HealthDay Reporter ... new type of sensor for people with diabetes is being ... instead of blood, researchers report. Scientists at Brown University ... using artificial saliva. It uses light, metal and a special ... "Everybody knows that diabetics have to prick their fingers to ...
Breaking Medicine News(10 mins):Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
Other TagsOther Tags